Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jemison Investment Co., Inc. is a private investment firm and diversified holding company based in Birmingham, Alabama. Founded in 1949 by John S. Jemison Jr., the firm manages a broad portfolio of businesses across various sectors, including industrial manufacturing, real estate, and financial services. While not a dedicated drug developer, Jemison Investment is recognized in the life sciences sector for its pivotal role as a foundational and long-term investor in BioCryst Pharmaceuticals. The company operates primarily as a family-office-style investment vehicle, focusing on long-term value creation and strategic growth within its portfolio companies. Its involvement in the healthcare industry is characterized by providing patient capital and strategic guidance to innovative biotech and medical technology firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jemison Investment.